Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection
Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection
About this item
Full title
Author / Creator
Publisher
United States: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
United States: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
The efficacy of azithromycin vs. doxycycline for urogenital
Chlamydia trachomatis
infection was assessed in this randomized clinical trial. In a directly observed treatment context, the efficacy of azithromycin was 97% and that of doxycycline was 100%.
Urogenital
Chlamydia trachomatis
infection is the most prevalent bacterial sexuall...
Alternative Titles
Full title
Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4708266
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4708266
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1502599
